The manufacturing of medicinal products is for us not only a matter of implementing a certain technological process, but a human mission based on high standards of quality, safety and efficacy of medications
Sofia, Bulgaria, January 10, 2024 – In accordance with the requirements of art. 100 of LPOS “Sopharma” AD (SFA: Bulgarian Stock Exchange, SPH: Warsaw Stock Exchange) notifies that on January 22, 2024 the Company will initiate the payment of the dividend for the 6 months of 2023 of 90 stotinki voted on the Extraordinary General Meeting of Shareholders held on November 24, 2023.
The shareholders eligible for dividend are those registered in the book of shareholders 14 days after the date of the EGM on which the distribution of dividend was voted, i.e. December 08, 2023.
Sofia, Bulgaria, December 22 2023 – According to the requirements of art. 17 of the Regulation (EU) No 596/2014 of the European Parliament and of the Council, “Sopharma” AD (SFA: Bulgarian Stock Exchange, SPH: Warsaw Stock Exchange) notifies that on December 22, 2023 the Company bought 20 000 (twenty thousand) own shares representing 0.0116% of the share capital of the Company, at a total value of BGN 114 400,00 on the Bulgarian Stock Exchange, the average price per share was BGN 5,72.
Sofia, Bulgaria, December 22 2023 – According to the requirements of art. 17 of the Regulation (EU) No 596/2014 of the European Parliament and of the Council, “Sopharma” AD (SFA: Bulgarian Stock Exchange, SPH: Warsaw Stock Exchange) notifies that on December 21, 2023 the Company bought 20 000 (twenty thousand) own shares representing 0.0116% of the share capital of the Company, at a total value of BGN 116 000,00 on the Bulgarian Stock Exchange, the average price per share was BGN 5,80.
Sofia, Bulgaria, December 21, 2023 - Pursuant to the requirements of Art. 100t of the Law on Public Offering of Securities, "Sopharma" AD (SFA: BSE AD, SPH: Warsaw Stock Exchange) announces that on the basis of Art. 187b of the Commercial Law and Art. 111, para. 5 and para.
Sofia, Bulgaria, December 21 2023 – According to the requirements of art. 17 of the Regulation (EU) No 596/2014 of the European Parliament and of the Council, “Sopharma” AD (SFA: Bulgarian Stock Exchange, SPH: Warsaw Stock Exchange) notifies that on December 20, 2023 the Company bought 30 000 (thirty thousand) own shares representing 0.0174% of the share capital of the Company, at a total value of BGN 177 000,00 on the Bulgarian Stock Exchange, the average price per share was BGN 5,90.
